Metformin reduces the risk of cancer in diabetics

Recently, a research report by Mexican scientists has been published at the American Endocrinology Annual Meeting, saying that regular use of diabetes medication metformin can reduce the risk of certain diseases. Cancer in patients with type 2 diabetes.

>>>Find out the "culprit" that makes diabetic patients suffer

Leading the research group, Diego Espinoza-Peralta said they conducted a meta-analysis of seven studies including 3,400 subjects. The results showed that the risk of cancer in patients with type 2 diabetes who use metformin is relatively low, only about 38%. The most obvious is the reduction in the risk of bowel and breast cancer, but it does not have a clear change in pancreatic cancer.

Among patients with type 2 diabetes, bowel cancer, breast cancer and pancreatic cancer are the three most at risk of developing cancer.

Diego Espinoza-Peralta explained that metformin reduces the risk of cancer in patients with type 2 diabetes because it can regulate an enzyme activity that helps inhibit cell growth.

Metformin is a medicine that is considered safe for long-term use. Previous studies have shown that the drug may inhibit tumor growth in the lungs and breast, reducing the risk of breast cancer in people with type 2 diabetes.